Biodesix receives Nasdaq deficiency notice for bid price below $1.00 per share

BIODESIX INC

Nasdaq notified Biodesix on March 24, 2025 that bid price closed below $1.00 for 30 consecutive business days.
Company has 180 calendar days, until September 22, 2025, to regain compliance with minimum bid price rule.
To cure, closing bid price must be at least $1.00 for 10 consecutive business days before Compliance Date.
If not cured by Sep 22, may be eligible for additional 180-day period on Nasdaq Capital Market if other standards met.
Company may consider reverse stock split to increase bid price; no assurance of regaining compliance.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.